Nikulski Financial Inc. Has $7.16 Million Position in Lam Research Corporation $LRCX

Nikulski Financial Inc. lowered its holdings in Lam Research Corporation (NASDAQ:LRCXFree Report) by 18.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,818 shares of the semiconductor company’s stock after selling 9,523 shares during the quarter. Lam Research accounts for about 1.7% of Nikulski Financial Inc.’s investment portfolio, making the stock its 15th biggest position. Nikulski Financial Inc.’s holdings in Lam Research were worth $7,161,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC acquired a new stake in Lam Research during the fourth quarter valued at approximately $25,000. Stance Capital LLC acquired a new position in shares of Lam Research in the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research in the 2nd quarter worth approximately $27,000. Triumph Capital Management bought a new position in shares of Lam Research during the 3rd quarter worth approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new position in shares of Lam Research during the 2nd quarter worth approximately $29,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

Insider Activity

In related news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the transaction, the director owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the sale, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 130,886 shares of company stock valued at $29,658,802 over the last 90 days. 0.31% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on LRCX. Summit Insights upgraded Lam Research from a “hold” rating to a “buy” rating in a research report on Thursday, January 29th. Susquehanna set a $325.00 price objective on Lam Research and gave the company a “positive” rating in a report on Thursday, January 29th. Sanford C. Bernstein boosted their target price on shares of Lam Research from $275.00 to $285.00 and gave the company an “outperform” rating in a research note on Monday, February 9th. Citic Securities upped their target price on shares of Lam Research from $165.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Finally, New Street Research increased their target price on shares of Lam Research from $195.00 to $235.00 and gave the stock a “neutral” rating in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.35.

Read Our Latest Stock Analysis on LRCX

Lam Research Price Performance

LRCX opened at $213.66 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The stock has a market capitalization of $266.81 billion, a P/E ratio of 43.78, a price-to-earnings-growth ratio of 2.15 and a beta of 1.77. The company’s 50 day simple moving average is $227.18 and its 200-day simple moving average is $183.68. Lam Research Corporation has a one year low of $56.32 and a one year high of $256.68.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s revenue was up 22.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is 21.31%.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.